SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+9.74%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$554M
AUM Growth
+$554M
(-2.4%)
Cap. Flow
-$70.7M
Cap. Flow
% of AUM
-12.76%
Top 10 Holdings %
Top 10 Hldgs %
48.85%
Holding
147
New
23
Increased
32
Reduced
53
Closed
29
Top Buys
| 1 |
Ormat Technologies
ORA
|
$19.9M |
| 2 |
Pfizer
PFE
|
$19.5M |
| 3 |
Biogen
BIIB
|
$11.9M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$5.76M |
| 5 |
Opko Health
OPK
|
$5.03M |
Top Sells
| 1 |
Elbit Systems
ESLT
|
$29.2M |
| 2 |
SHPG
Shire pic
SHPG
|
$26.6M |
| 3 |
AGN
Allergan plc
AGN
|
$24.1M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$12.7M |
| 5 |
Viatris
VTRS
|
$8.05M |
Sector Composition
| 1 | Healthcare | 74.78% |
| 2 | Utilities | 7.14% |
| 3 | Technology | 2.29% |
| 4 | Consumer Discretionary | 1.7% |
| 5 | Communication Services | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDZ
51
DELISTED
Immune Design Corp.
IMDZ
| $3.07M | 0.45% | 153,000 -17,000 | -10% | -$341K |
|
52
Arrowhead Research
ARWR
$3.05B
| $2.99M | 0.44% | 486,000 -54,000 | -10% | -$332K |
|
53
Mastercard
MA
$538B
| $2.98M | 0.44% | +30,605 | New | +$2.98M |
|
|
XLRN
54
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.93M | 0.43% | 60,000 -40,000 | -40% | -$1.95M |
|
|
GNCA
55
DELISTED
Genocea Biosciences, Inc.
GNCA
| $2.85M | 0.42% | 540,490 +163,290 | +43% | +$860K |
|
56
Visa
V
$683B
| $2.84M | 0.42% | +36,600 | New | +$2.84M |
|
57
Starbucks
SBUX
$100B
| $2.81M | 0.41% | 46,828 -15,855 | -25% | -$952K |
|
|
FOMX
58
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.77M | 0.41% | 342,000 -38,000 | -10% | -$308K |
|
|
BITI
59
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
| $2.74M | 0.4% | 193,646 -3,154 | -2% | -$44.6K |
|
|
PTNR
60
DELISTED
Partner Communications
PTNR
| $2.7M | 0.4% | 617,951 | – | – |
|
61
Honeywell
HON
$139B
| $2.65M | 0.39% | +25,595 | New | +$2.65M |
|
62
Travere Therapeutics
TVTX
$1.56B
| $2.6M | 0.38% | 135,000 -15,000 | -10% | -$289K |
|
|
ITCI
63
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.6M | 0.38% | 48,400 -57,000 | -54% | -$3.07M |
|
64
uniQure
QURE
$896M
| $2.54M | 0.37% | 153,500 +38,500 | +33% | +$637K |
|
65
Exelixis
EXEL
$10.1B
| $2.54M | 0.37% | 450,000 -50,000 | -10% | -$282K |
|
|
CLCD
66
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $2.39M | 0.35% | 285,525 -31,725 | -10% | -$266K |
|
67
Advance Auto Parts
AAP
$3.66B
| $2.34M | 0.34% | +15,555 | New | +$2.34M |
|
68
Halozyme
HALO
$8.56B
| $2.34M | 0.34% | 135,000 -15,000 | -10% | -$260K |
|
69
Summit Therapeutics
SMMT
$17.6B
| $2.32M | 0.34% | 202,220 -2,980 | -1% | -$34.2K |
|
|
FWP
70
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $2.31M | 0.34% | 121,500 -13,500 | -10% | -$257K |
|
|
DMTX
71
DELISTED
Dimension Therapeutics, Inc
DMTX
| $2.26M | 0.33% | +200,000 | New | +$2.26M |
|
|
MDCO
72
DELISTED
Medicines Co
MDCO
| $2.24M | 0.33% | +60,000 | New | +$2.24M |
|
73
Cognizant
CTSH
$35.3B
| $2.2M | 0.32% | +36,600 | New | +$2.2M |
|
74
Dynavax Technologies
DVAX
$1.19B
| $2.17M | 0.32% | 90,000 -10,000 | -10% | -$242K |
|
|
VTAE
75
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $2.17M | 0.32% | +120,000 | New | +$2.17M |
|